Search

Your search keyword '"Moosavi, MA"' showing total 60 results

Search Constraints

Start Over You searched for: Author "Moosavi, MA" Remove constraint Author: "Moosavi, MA"
60 results on '"Moosavi, MA"'

Search Results

1. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.

4. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019:A Systematic Analysis for the Global Burden of Disease Study 2019

5. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.

6. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

7. Mapping routine measles vaccination in low- and middle-income countries

8. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

13. The impact of nanomaterials on autophagy across health and disease conditions.

14. Metal-based nanoparticles in cancer therapy: Exploring photodynamic therapy and its interplay with regulated cell death pathways.

15. Expression and Clinical Significance of IRE1-XBP1s, p62, and Caspase-3 in Colorectal Cancer Patients.

16. Inhibition of IRE1 RNase activity modulates tumor cell progression and enhances the response to chemotherapy in colorectal cancer.

17. Exploring the Complex Link between Autophagy, Regulated Cell Death, and Cell Fate Pathways in Cancer Pathogenesis and Therapy.

18. The International Natural Product Sciences Taskforce (INPST) and the power of Twitter networking exemplified through #INPST hashtag analysis.

19. Exosomes, autophagy and ER stress pathways in human diseases: Cross-regulation and therapeutic approaches.

20. Exploring the role of non-coding RNAs in autophagy.

21. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.

22. TRAIL Triggers CRAC-Dependent Calcium Influx and Apoptosis through the Recruitment of Autophagy Proteins to Death-Inducing Signaling Complex.

23. Evaluation of squamous cell carcinoma antigen 1 expression in oral squamous cell carcinoma (tumor cells and peritumoral T-lymphocytes) and verrucous carcinoma and comparison with normal oral mucosa.

24. Potential toxicity of nanoparticles on the reproductive system animal models: A review.

25. Combination therapy with TiO 2 nanoparticles and cisplatin enhances chemotherapy response in murine melanoma models.

26. Effects of different autophagy inhibitors on sensitizing KG-1 and HL-60 leukemia cells to chemotherapy.

27. New insights on the role of autophagy in the pathogenesis and treatment of melanoma.

28. Differential effects of N-TiO 2 nanoparticle and its photo-activated form on autophagy and necroptosis in human melanoma A375 cells.

29. TiO 2 nanoparticles enhance the chemotherapeutic effects of 5-fluorouracil in human AGS gastric cancer cells via autophagy blockade.

30. A siRNA-based method for efficient silencing of PYROXD1 gene expression in the colon cancer cell line HCT116.

31. The Increased RNase Activity of IRE1α in PBMCs from Patients with Rheumatoid Arthritis.

32. Autophagy: New Insights into Mechanisms of Action and Resistance of Treatment in Acute Promyelocytic leukemia.

33. Anti-oxidant and Selective Anti-proliferative Effects of the Total Cornicabra Olive Polyphenols on Human Gastric MKN45 Cells.

34. Necrotic, apoptotic and autophagic cell fates triggered by nanoparticles.

35. Health Concerns of Various Nanoparticles: A Review of Their in Vitro and in Vivo Toxicity.

36. ER Stress: A Therapeutic Target in Rheumatoid Arthritis?

37. Phytochemicals as potent modulators of autophagy for cancer therapy.

38. Nucleostemin silencing induces differentiation and potentiates all-trans-retinoic acid effects in human acute promyelocytic leukemia NB4 cells via autophagy.

39. New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets.

40. Evaluation of the cytotoxic, apoptosis inducing activity and molecular docking of spiroquinazolinone benzamide derivatives in MCF-7 breast cancer cells.

41. A bio-mimetic zinc/tau protein as an artificial catalase.

42. Photodynamic N-TiO 2 Nanoparticle Treatment Induces Controlled ROS-mediated Autophagy and Terminal Differentiation of Leukemia Cells.

43. Modeling and structural analysis of human Guanine nucleotide-binding protein-like 3,nucleostemin.

44. Nucleostemin knocking-down causes cell cycle arrest and apoptosis in human T-cell acute lymphoblastic leukemia MOLT-4 cells via p53 and p21Waf1/Cip1 up-regulation.

45. Nucleostemin depletion induces post-g1 arrest apoptosis in chronic myelogenous leukemia k562 cells.

46. Carbenoxolone induces apoptosis and inhibits survivin and survivin-ΔEx3 genes expression in human leukemia K562 cells.

47. Distinct MAPK signaling pathways, p21 up-regulation and caspase-mediated p21 cleavage establishes the fate of U937 cells exposed to 3-hydrogenkwadaphnin: differentiation versus apoptosis.

49. ERK1/2 inactivation and p38 MAPK-dependent caspase activation during guanosine 5'-triphosphate-mediated terminal erythroid differentiation of K562 cells.

50. 3-Hydrogenkwadaphnin induces monocytic differentiation and enhances retinoic acid-mediated granulocytic differentiation in NB4 cell line.

Catalog

Books, media, physical & digital resources